iStreet Network Ltd. is identified as a deep value pick despite its poor financial performance, as it is currently undervalued compared to its peers in the Pharmaceuticals & Drugs sector. However, it faces significant challenges given its negative profitability metrics and lack of growth. Meanwhile, companies like Sun Pharmaceuticals and Dr. Reddy's Laboratories stand out as strong performers with robust profitability and growth metrics, while iStreet is financially precarious.

• • iStreet Network Ltd has the lowest revenue growth metrics and significant negative EPS values, indicating poor performance compared to peers.
• • Sun Pharmaceutical Industries Ltd. and Dr. Reddy's Laboratories Ltd. exhibit strong profitability and growth, making them sector leaders.
• • High valuation ratios for iStreet highlight its potential as a deep value pick despite its underperformance.